384 related articles for article (PubMed ID: 34128132)
1. Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors.
Tian Z; Mai Y; Meng T; Ma S; Gou G; Yang J
AAPS PharmSciTech; 2021 Jun; 22(5):179. PubMed ID: 34128132
[TBL] [Abstract][Full Text] [Related]
2. Nanocrystals Technology for Improving Bioavailability of Poorly Soluble Drugs: A Mini-Review.
Zhou Y; Du J; Wang L; Wang Y
J Nanosci Nanotechnol; 2017 Jan; 17(1):18-28. PubMed ID: 29616786
[TBL] [Abstract][Full Text] [Related]
3. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
[TBL] [Abstract][Full Text] [Related]
4. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.
Gao L; Liu G; Ma J; Wang X; Zhou L; Li X; Wang F
Pharm Res; 2013 Feb; 30(2):307-24. PubMed ID: 23073665
[TBL] [Abstract][Full Text] [Related]
5. Nanocrystal for ocular drug delivery: hope or hype.
Sharma OP; Patel V; Mehta T
Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
Cai Z; Wang Y; Zhu LJ; Liu ZQ
Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
[TBL] [Abstract][Full Text] [Related]
8. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
Okur NÜ; Siafaka PI; Gökçe EH
Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
[TBL] [Abstract][Full Text] [Related]
9. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Wang XQ; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
[TBL] [Abstract][Full Text] [Related]
10. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
11. Ligand-mediated active targeting for enhanced oral absorption.
Zhang X; Wu W
Drug Discov Today; 2014 Jul; 19(7):898-904. PubMed ID: 24631680
[TBL] [Abstract][Full Text] [Related]
12. Nanocrystals: An Overview of Fabrication, Characterization and Therapeutic Applications in Drug Delivery.
Pardhi VP; Verma T; Flora SJS; Chandasana H; Shukla R
Curr Pharm Des; 2018; 24(43):5129-5146. PubMed ID: 30767737
[TBL] [Abstract][Full Text] [Related]
13. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Singh G; Pai RS
J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
[TBL] [Abstract][Full Text] [Related]
14. Factors and dosage formulations affecting the solubility and bioavailability of P-glycoprotein substrate drugs.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2021 May; 17(5):555-580. PubMed ID: 33703995
[No Abstract] [Full Text] [Related]
15. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
16. Nanocrystals based mucosal delivery system: research advances.
Liu Y; Shuai S; Huang G; Chen Y; Shen B; Yue P
Drug Dev Ind Pharm; 2021 Nov; 47(11):1700-1712. PubMed ID: 35287534
[TBL] [Abstract][Full Text] [Related]
17. Progress in the study of drug nanocrystals.
Shi J; Guo F; Zheng A; Zhang X; Sun J
Pharmazie; 2015 Dec; 70(12):757-64. PubMed ID: 26817271
[TBL] [Abstract][Full Text] [Related]
18. Nanocrystal technology in the delivery of poorly soluble drugs: an overview.
Nagarwal RC; Kumar R; Dhanawat M; Das N; Pandit JK
Curr Drug Deliv; 2011 Jul; 8(4):398-406. PubMed ID: 21453258
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in the use of nanocrystals to improve bioavailability of APIs.
Ding Y; Zhao T; Fang J; Song J; Dong H; Liu J; Li S; Zhao M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1958. PubMed ID: 38629192
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
